164 related articles for article (PubMed ID: 36685857)
1. Transcriptomic data analysis coupled with copy number aberrations reveals a blood-based 17-gene signature for diagnosis and prognosis of patients with colorectal cancer.
Kaya IH; Al-Harazi O; Colak D
Front Genet; 2022; 13():1031086. PubMed ID: 36685857
[No Abstract] [Full Text] [Related]
2. Integrated Analysis of Transcriptomic and Genomic Data Reveals Blood Biomarkers With Diagnostic and Prognostic Potential in Non-small Cell Lung Cancer.
Kaya IH; Al-Harazi O; Kaya MT; Colak D
Front Mol Biosci; 2022; 9():774738. PubMed ID: 35309509
[No Abstract] [Full Text] [Related]
3. Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network Analyses.
Al-Harazi O; Kaya IH; Al-Eid M; Alfantoukh L; Al Zahrani AS; Al Sebayel M; Kaya N; Colak D
Front Genet; 2021; 12():710049. PubMed ID: 34659334
[No Abstract] [Full Text] [Related]
4. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
[TBL] [Abstract][Full Text] [Related]
5. A Network-Based Methodology to Identify Subnetwork Markers for Diagnosis and Prognosis of Colorectal Cancer.
Al-Harazi O; Kaya IH; El Allali A; Colak D
Front Genet; 2021; 12():721949. PubMed ID: 34790220
[TBL] [Abstract][Full Text] [Related]
6. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
7. Construction and Validation of a Novel Ferroptosis-Related lncRNA Signature to Predict Prognosis in Colorectal Cancer Patients.
Zhang W; Fang D; Li S; Bao X; Jiang L; Sun X
Front Genet; 2021; 12():709329. PubMed ID: 34777458
[No Abstract] [Full Text] [Related]
8. A novel prognostic model based on urea cycle-related gene signature for colorectal cancer.
Guo H; Wang Y; Gou L; Wang X; Tang Y; Wang X
Front Surg; 2022; 9():1027655. PubMed ID: 36338624
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
10. A prognostic index based on an eleven gene signature to predict systemic recurrences in colorectal cancer.
Kim SK; Kim SY; Kim CW; Roh SA; Ha YJ; Lee JL; Heo H; Cho DH; Lee JS; Kim YS; Kim JC
Exp Mol Med; 2019 Oct; 51(10):1-12. PubMed ID: 31578316
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
12. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X; Cheng Z; Chen X; Li J
Front Genet; 2022; 13():955424. PubMed ID: 36046241
[No Abstract] [Full Text] [Related]
13. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
Hammad A; Elshaer M; Tang X
Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
[TBL] [Abstract][Full Text] [Related]
14. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer.
Mo S; Dai W; Zhou Z; Gu R; Li Y; Xiang W; Han L; Zhang L; Wang R; Cai G; Cai S; Gan L; Li Q
Front Cell Dev Biol; 2021; 9():681431. PubMed ID: 34211976
[TBL] [Abstract][Full Text] [Related]
16. NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer.
O'Cathail SM; Wu CH; Lewis A; Holmes C; Hawkins MA; Maughan T
Cancer Genet; 2020 Oct; 248-249():1-10. PubMed ID: 32871287
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a 7-microRNA prognostic signature and identification of hub target genes in colorectal carcinoma.
Jiang S; Xie X; Jiang H
Transl Cancer Res; 2022 Feb; 11(2):367-381. PubMed ID: 35281422
[TBL] [Abstract][Full Text] [Related]
19. A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer.
Matsuyama T; Kandimalla R; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kinugasa Y; Hansen TF; Fakih M; Uetake H; Győrffy B; Goel A
Int J Cancer; 2020 Dec; 147(11):3250-3261. PubMed ID: 32657428
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer.
Wang QQ; Zhou YC; Zhou Ge YJ; Qin G; Yin TF; Zhao DY; Tan C; Yao SK
World J Clin Cases; 2022 Aug; 10(22):7686-7697. PubMed ID: 36158487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
